Literature DB >> 18033025

[Urea cycle disorders in adult patients].

F Maillot1, P Crenn.   

Abstract

INTRODUCTION: Urea cycle disorders (UCD) usually present after 24 h to 48 h of life with failure to thrive, lethargy and coma leading to death, but milder forms may occur from infancy to adulthood. STATE OF THE ART: Survival of children with UCD has significantly improved and the need for transitional care to adulthood has emerged. Adult onset UCD present with chronic or acute neurological, psychiatric and digestive symptoms associated with protein avoidance. Ornithine transcarbamylase (OTC) deficiency, which is inherited as an X-linked disorder, is the most well-described UCD in adults. Acute decompensations associate the triad of encephalopathy, respiratory alkalosis and hyperammonemia. Acute encephalopathy is characterized by brain edema, which is life-threatening without treatment. Specific urea cycle enzyme deficiency can be suspected in the presence of abnormal plasma amino acids concentrations and urinary excretion of orotic acid. A measurement enzyme activity in appropriate tissue, or DNA analysis if available, is required for diagnosis. Treatment requires restriction of dietary protein intake and the use of alternative pathways of waste nitrogen excretion with sodium benzoate and sodium phenylbutyrate. Patients with acute forms may need hemodialysis or hemodiafiltration. Therapeutic goals for OTC deficiency are to maintain plasma ammonia<80 micromol/L, plasma glutamine<1,000 micromol/L, argininemia 80-150 micromol/L and branched chain amino acids within the normal range, in order to prevent episodes of potentially lethal acute hyperammonemia.
CONCLUSION: Potentially fatal acute hyperammonemia may occur in male or female patients at any age. Ammonia should be measured promptly in case of acute neurological and psychiatric symptoms or coma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18033025     DOI: 10.1016/s0035-3787(07)92632-6

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  5 in total

Review 1.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 2.  Hyperammonemia due to urea cycle disorders: a potentially fatal condition in the intensive care setting.

Authors:  Marcel Cerqueira Cesar Machado; Fabiano Pinheiro da Silva
Journal:  J Intensive Care       Date:  2014-03-13

3.  Late-onset ornithine carbamoyltransferase deficiency accompanying acute pancreatitis and hyperammonemia.

Authors:  Marcel Cerqueira Cesar Machado; Gilton Marques Fonseca; José Jukemura
Journal:  Case Rep Med       Date:  2013-08-29

4.  Psychiatric adult-onset of urea cycle disorders: A case-series.

Authors:  Adrien Bigot; Paul Brunault; Christian Lavigne; François Feillet; Sylvie Odent; Elsa Kaphan; Christel Thauvin; Vanessa Leguy; Pierre Broué; Michel C Tchan; François Maillot
Journal:  Mol Genet Metab Rep       Date:  2017-07-06

5.  Acute Fulminant Encephalopathy in an Adult due to Ornithine Transcarbamylase Deficiency.

Authors:  Vivek K Nambiar; Aakash Shridharani; Sudheeran Kannoth; Siby Gopinath; Anand Kumar
Journal:  Ann Indian Acad Neurol       Date:  2022-08-04       Impact factor: 1.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.